HSHelen Sjöblom

Helen Sjöblom

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Helen Sjöblom has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Doctoral students’ reflection on Generative AI

    by Linda Hammarbäck, Helen Sjöblom, Sara Viklund, Eva Hessman

    This practice paper explores doctoral students’ perspectives on the use of generative AI and examines the role of librarians as mediators in this evolving field. Originating from a long-standing doctoral course on information literacy at the Biomedical Library, University of Gothenburg, the study integrates recent advancements in generative AI tools for summarizing and analyzing scientific articles. During the spring semester of 2024, students were introduced to these tools and tasked with incorporating them into their course assignments. This paper analyzes the reflections and insights from these assignments, in the context of their diverse backgrounds from various medical disciplines. The findings provide a nuanced understanding of the students’ views on generative AI and underscore the importance of librarians in facilitating the adoption of new technologies in academic research. The study concludes with reflections on the implications for future course content and the role of librarians in supporting research through technological advancements.

  • Open Access

    Understanding ageism towards older nursing staff and service users: A systematic mapping review from the perspective of clinical leaders and healthcare managers

    by Gerhilde Schüttengruber, Maja M Olsson, Christopher Holmberg, Franziska Großschädl, Eva Hessman, Helen Sjöblom, Birgit Heckemann


  • Open Access

    Do Interventions with Diet or Dietary Supplements Reduce the Disease Activity Score in Rheumatoid Arthritis? A Systematic Review of Randomized Controlled Trials

    by Josefine Nelson, Helen Sjöblom, Inger Gjertsson, Stine M. Ulven, Helen M. Lindqvist, Linnea Bärebring

    The aim was to compile the evidence from Randomized Controlled Trials (RCTs) of diet or dietary supplements used to reduce disease activity in adults with Rheumatoid Arthritis (RA). Searches were performed in the databases PubMed, Scopus and Cochrane. Only RCT studies of diets, foods or dietary supplements, looking at effects on the Disease Activity Score in 28 joints (DAS28) among adults with RA, published in peer-reviewed journals, were included. A total of 27 articles were included—three of whole diets (Mediterranean diet, raw food and anti-inflammatory diet), five of food items, five of n-3 fatty acids, five of single micronutrient supplements, four of single antioxidant supplements and five of pre-, pro- or synbiotics. Studies that showed moderate strength evidence for positive effects on disease activity in RA included interventions with a Mediterranean diet, spices (ginger powder, cinnamon powder, saffron), antioxidants (quercetin and ubiquinone), and probiotics containing Lactobacillus Casei. Other diets or supplements had either no effects or low to very low strength of evidence. In conclusion, RCT studies on diet or dietary supplements are limited in patients with RA, but based on the results in this review there is evidence that some interventions might have positive effects on DAS28.


  • Top Cited Papers

    Causes and outcomes in studies of fear of childbirth: A systematic review

    by Anna Dencker, Christina Nilsson, Cecily Begley, Elisabeth Jangsten, Margareta Mollberg, Harshida Patel, Helena Wigert, Eva Hessman, Helen Sjöblom, Carina Sparud-Lundin


  • Top Cited Papers
    Open Access

    Definitions, measurements and prevalence of fear of childbirth: a systematic review

    by C. Nilsson, E. Hessman, H. Sjöblom, A. Dencker, E. Jangsten, M. Mollberg, H. Patel, C. Sparud-Lundin, H. Wigert, C. Begley

    Fear of Childbirth (FOC) is a common problem affecting women’s health and wellbeing, and a common reason for requesting caesarean section. The aims of this review were to summarise published research on prevalence of FOC in childbearing women and how it is defined and measured during pregnancy and postpartum, and to search for useful measures of FOC, for research as well as for clinical settings. Five bibliographic databases in March 2015 were searched for published research on FOC, using a protocol agreed a priori. The quality of selected studies was assessed independently by pairs of authors. Prevalence data, definitions and methods of measurement were extracted independently from each included study by pairs of authors. Finally, some of the country rates were combined and compared. In total, 12,188 citations were identified and screened by title and abstract; 11,698 were excluded and full-text of 490 assessed for analysis. Of these, 466 were excluded leaving 24 papers included in the review, presenting prevalence of FOC from nine countries in Europe, Australia, Canada and the United States. Various definitions and measurements of FOC were used. The most frequently-used scale was the W-DEQ with various cut-off points describing moderate, severe/intense and extreme/phobic fear. Different 3-, 4-, and 5/6 point scales and visual analogue scales were also used. Country rates (as measured by seven studies using W-DEQ with ≥85 cut-off point) varied from 6.3 to 14.8%, a significant difference (chi-square = 104.44, d.f. = 6, p < 0.0001). Rates of severe FOC, measured in the same way, varied in different countries. Reasons why FOC might differ are unknown, and further research is necessary. Future studies on FOC should use the W-DEQ tool with a cut-off point of ≥85, or a more thoroughly tested version of the FOBS scale, or a three-point scale measurement of FOC using a single question as ‘Are you afraid about the birth?’ In this way, valid comparisons in research can be made. Moreover, validation of a clinical tool that is more focussed on FOC alone, and easier than the longer W-DEQ, for women to fill in and clinicians to administer, is required.